Stueland Katherine's Form 4 filing
GeneDx Holdings Corp. (WGS) · filed Sep 11, 2026
- Accession no.
- 0001689575-26-000030
- Filed
- Sep 11, 2026, 4:13 PM ET
- Trade date
- Sep 9, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $310.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stueland KatherineCIK 0001689575 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Class A Common Stock | MOption exerciseAcquired | +6,547 | $0.00 | $0 | 110,919 | Direct | |
| Sep 9, 2026 | Class A Common Stock | SSaleDisposed | −3,692 | $84.22 | −$310,932.12 | 107,227 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Class A Common Stock | MOption exerciseDisposed | −6,547 | $0.00 | $0 | 6,547 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.